Oxitriptan

This classification denotes an amino acid derivative with the molecular formula C11H12N2O3, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier C1LJO185Q9, chemically known as tryptophan, 5-hydroxy-, l- but more generally known as oxitriptan, which bears U.S. NIH Compound Identifier 144. European Medicines Agency schedules Oxitriptan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09541MIG. The term OXITRIPTAN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules oxitriptan in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary. OXITRIPTAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.